Patents by Inventor Hartmut Engelmann

Hartmut Engelmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5621077
    Abstract: Human natural IFN-.beta.2/IL-6 receptor and its soluble extracellular fragment are provided in substantially purified form and are shown to stimulate and to enhance beneficial effects of IFN-.beta.2/IL-6, such as its antiproliferative activity. Polyclonal and monoclonal antibodies raised against the soluble fragment of the receptor are also provided.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: April 15, 1997
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Daniela Novick, Louise Chen, Hartmut Engelmann, Michel Revel, Menachem Rubinstein, David Wallach
  • Patent number: 5359037
    Abstract: Antibodies to TNF Binding Protein I (TBP-I) are provided that can be used in diagnostic assays and as pharmaceutical agents for either inhibiting or mimicking the effects of TNF on cells.
    Type: Grant
    Filed: August 6, 1990
    Date of Patent: October 25, 1994
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Hartmut Engelmann, Dan Aderka
  • Patent number: 5216128
    Abstract: Human natural IFN-.beta.2/IL-6 receptor and its soluble extracellular fragment are provided in substantially purified form and are shown to stimulate and to enhance beneficial effects of IFN-.beta.2/IL-6, such as its antiproliferative activity. Polyclonal and monoclonal antibodies raised against the soluble fragment of the receptor are also provided.
    Type: Grant
    Filed: May 30, 1990
    Date of Patent: June 1, 1993
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Daniela Novick, Louise Chen, Hartmut Engelmann, Michel Revel, Menachem Rubinstein, David Wallach